tranexamic acid has been researched along with Dermatitis, Atopic in 1 studies
Tranexamic Acid: Antifibrinolytic hemostatic used in severe hemorrhage.
Dermatitis, Atopic: A chronic inflammatory genetically determined disease of the skin marked by increased ability to form reagin (IgE), with increased susceptibility to allergic rhinitis and asthma, and hereditary disposition to a lowered threshold for pruritus. It is manifested by lichenification, excoriation, and crusting, mainly on the flexural surfaces of the elbow and knee. In infants it is known as infantile eczema.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| López González, G | 1 |
| Parra, C | 1 |
| Billene, RN | 1 |
| Ortíz Medina, AH | 1 |
| Grinberg, AJ | 1 |
1 other study available for tranexamic acid and Dermatitis, Atopic
| Article | Year |
|---|---|
[Actinic prurigo. Treatment with antifibribolytics].
Topics: Adolescent; Adult; Aminocaproic Acid; Antifibrinolytic Agents; Dermatitis, Atopic; Drug Evaluation; | 1979 |